Collegium Pharmaceutical Inc (COLL)
30.40
+0.40
(+1.33%)
USD |
NASDAQ |
Nov 21, 16:00
30.40
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical Revenue (Quarterly): 159.30M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 159.30M |
| June 30, 2024 | 145.28M |
| March 31, 2024 | 144.92M |
| December 31, 2023 | 149.74M |
| September 30, 2023 | 136.71M |
| June 30, 2023 | 135.55M |
| March 31, 2023 | 144.77M |
| December 31, 2022 | 129.62M |
| September 30, 2022 | 127.01M |
| June 30, 2022 | 123.55M |
| March 31, 2022 | 83.75M |
| December 31, 2021 | 27.36M |
| September 30, 2021 | 78.84M |
| June 30, 2021 | 82.94M |
| March 31, 2021 | 87.72M |
| December 31, 2020 | 76.27M |
| September 30, 2020 | 79.18M |
| Date | Value |
|---|---|
| June 30, 2020 | 78.06M |
| March 31, 2020 | 76.51M |
| December 31, 2019 | 74.20M |
| September 30, 2019 | 72.94M |
| June 30, 2019 | 75.04M |
| March 31, 2019 | 74.52M |
| December 31, 2018 | 73.43M |
| September 30, 2018 | 70.18M |
| June 30, 2018 | 73.06M |
| March 31, 2018 | 63.75M |
| December 31, 2017 | 10.79M |
| September 30, 2017 | 11.95M |
| June 30, 2017 | 3.56M |
| March 31, 2017 | 2.172M |
| December 31, 2016 | 1.303M |
| September 30, 2016 | 0.408M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
27.36M
Minimum
Dec 2021
159.30M
Maximum
Sep 2024
107.06M
Average
105.64M
Median
Revenue (Quarterly) Benchmarks
| Pfizer Inc | 17.70B |
| Context Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 2.441M |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 9.335M |
| Total Expenses (Quarterly) | 124.46M |
| EPS Diluted (Quarterly) | 0.27 |
| Enterprise Value | 1.715B |
| Gross Profit Margin (Quarterly) | 60.76% |
| Profit Margin (Quarterly) | 5.86% |
| Earnings Yield | 7.66% |
| Operating Earnings Yield | 13.86% |
| Normalized Earnings Yield | 8.263 |